SBI Securities Co., Ltd.
Broker-DealerPosition in ADPT — Adaptive Biotechnologies Corp
CIK 1851815
TOKYO, M0
Position in ADPT
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$2,702
+$2,702 QoQ
Shares Held
32
+39.1% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#61
of 70 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ADPT Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026SBI Securities Co., Ltd. holds $2,257,221 across 36 Diagnostics & Research names. ADPT ranks #21 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | DHR |
Danaher Corp /De/
|
2,215 | $421,913 | |
| 2 | ILMN |
Illumina, Inc.
|
1,832 | $322,120 | |
| 3 | TMO |
Thermo Fisher Scientific Inc.
|
561 | $281,262 | |
| 4 | GH |
Guardant Health, Inc.
|
1,850 | $277,555 | |
| 5 | A |
Agilent Technologies, Inc.
|
1,270 | $168,694 | |
| 6 | NTRA |
Natera, Inc.
|
598 | $162,327 | |
| 7 | WAT |
Waters Corp /De/
|
383 | $143,640 | |
| 8 | IDXX |
Idexx Laboratories Inc /De
|
223 | $117,396 |
All Filings in ADPT
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,702 | 126 | Shares | Defined | 2026-07-23 | |
| 2026-03-31 | — | 91 | Shares | Defined | 2026-04-28 | |
| 2025-12-31 | — | 51 | Shares | Defined | 2026-02-03 | |
| 2025-09-30 | — | 368 | Shares | Defined | 2025-11-05 | |
| 2025-06-30 | — | 286 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | — | 286 | Shares | Defined | 2025-05-02 | |
| 2024-12-31 | — | 286 | Shares | Defined | 2025-02-06 | |
| No filing history on record for this holder in this stock. | ||||||